Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer in comparison with chemoradiotherapy alone

BACKGROUND: Durvalumab after concurrent chemoradiotherapy (CCRT) for locally advanced non‐small cell lung cancer (LA‐NSCLC) has been found to significantly improve overall survival (OS). However, the effect of durvalumab on local control remains unclear. Here, we evaluated the effect of the durvalum...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Thorac Cancer
Auteurs principaux: Abe, Takanori, Saito, Satoshi, Iino, Misaki, Aoshika, Tomomi, Ryuno, Yasuhiro, Ohta, Tomohiro, Igari, Mitsunobu, Hirai, Ryuta, Kumazaki, Yu, Miura, Yu, Kaira, Kyoichi, Kagamu, Hiroshi, Noda, Shin‐ei, Kato, Shingo
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons Australia, Ltd 2020
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812072/
https://ncbi.nlm.nih.gov/pubmed/33289347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13764
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires